BioProspect
BioProspect (ASX: BPO) holds investments in Philippines oil and gas assets and also operates in the biotechnology industry focusing on natural plant extracts for use within the insecticide, termiticide and human health markets.
BioProspect to re-enter Philippines well, could develop power plant
Wednesday, February 08, 2012 by Bevis Yeo
BioProspect (ASX: BPO) expects the Nassiping-2 re-entry well at Service Contract 52 onshore Luzon Island, Philippines, targeting up to 350 billion cubic feet of gas to spud soon.
The Aztec Rig 7 is currently on site with work continuing to test equipment and complete preparations ahead of the re-entry.
Nassiping-2 is a previously discovered but untested gas discovery with estimated contingent resources of 35 to 350 billion cubic feet of gas.
The target Nassiping Dome is located just 700 metres from the national power grid, giving the SC52 partners the opportunity to commercialise the project by developing a medium-scale gas-fired power plant.
BioProspect holds a 50% stake in Frontier Gasfields, which in turns own 30% of SC52. BioProspect retains an option to further increase its stake in Frontier to 75%.
Other partners are Frontier Oil with 50% and E.F. Durkee & Associate with 10% though Trans-Asia Oil and Energy Development Corporation has signed a farm-in deal with Frontier Oil to acquire a 10% stake in SC52.
No investment advice
The Company is a publisher and is not registered with or authorised by the Financial Services Authority (FSA). You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.
You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.
From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.
